Propiomazina [Inn-Spanish]
Brand names,
Propiomazina [Inn-Spanish]
Analogs
Propiomazina [Inn-Spanish]
Brand Names Mixture
Propiomazina [Inn-Spanish]
Chemical_Formula
C20H24N2OS
Propiomazina [Inn-Spanish]
RX_link
No information avaliable
Propiomazina [Inn-Spanish]
fda sheet
Propiomazina [Inn-Spanish]
msds (material safety sheet)
Propiomazina [Inn-Spanish]
Synthesis Reference
No information avaliable
Propiomazina [Inn-Spanish]
Molecular Weight
340.483 g/mol
Propiomazina [Inn-Spanish]
Melting Point
No information avaliable
Propiomazina [Inn-Spanish]
H2O Solubility
0.454 mg/L
Propiomazina [Inn-Spanish]
State
Solid
Propiomazina [Inn-Spanish]
LogP
5.224
Propiomazina [Inn-Spanish]
Dosage Forms
Injection (20 mg/mL)
Propiomazina [Inn-Spanish]
Indication
Used to produce sleepiness or drowsiness and to relieve anxiety before or during surgery or certain procedures. Also used with analgesics during labor to produce drowsiness and relieve anxiety.
Propiomazina [Inn-Spanish]
Pharmacology
Propiomazine, an atypical antipsychotic agent, is used to treat both negative and positive symptoms of schizophrenia, acute mania with bipolar disorder, agitation, and psychotic symptoms in dementia. Future uses may include the treatment of obsessive-compulsive disorder and severe behavioral disorders in autism. Structurally and pharmacologically similar to clozapine, propiomazine binds to alpha(1), dopamine, histamine H1, muscarinic, and serotonin type 2 (5-HT2) receptors.
Propiomazina [Inn-Spanish]
Absorption
No information avaliable
Propiomazina [Inn-Spanish]
side effects and Toxicity
Rare, serious side effects include convulsions (seizures); difficult or unusually fast breathing; fast or irregular heartbeat or pulse; fever (high); high or low blood pressure; loss of bladder control; muscle stiffness (severe); unusual increase in sweating; unusually pale skin; and unusual tiredness or weakness.
Propiomazina [Inn-Spanish]
Patient Information
No information avaliable
Propiomazina [Inn-Spanish]
Organisms Affected
Humans and other mammals